Showing results (6271-6280 of 27,720) with videos related to
Sort By:
Pageof 2,772
Vaccine|September 5, 2024
Salp14 epitope-based mRNA vaccination induces early recognition of a tick biteYingjun Cui, Balasubramanian Cibichakravarthy, Xiaotian Tang, et al.Vaccine|September 6, 2024
Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY)Kevin M Tuffy, Bahar Ahani, Joseph B Domachowske, et al.Vaccine|September 6, 2024
Disparities in COVID-19 vaccination receipt by race, ethnicity, and social determinants of health among a large patient population in a network of community-based healthcare centersHolly C Groom, Frances M Biel, Bradley Crane, et al.Vaccine|August 29, 2024
Shedding reduction and immunity modulation in piglets with an inactivated Mycoplasma hyopneumoniae vaccine encapsulated in nanostructured SBA-15 silicaFernando Antonio Moreira Petri, Clarisse Sena Malcher, Marina Lopes Mechler-Dreibi, et al.Vaccine|September 4, 2024
Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021Christine Kim, Christopher Dunphy, Christopher Duggar, et al.Vaccine|September 11, 2024
Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concernJungmin Chun, Doyoung Yoon, Aleksandra Nowakowska, et al.Vaccine|September 6, 2024
A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hostsAna Maria Valencia-Hernandez, Guangzu Zhao, Socorro Miranda-Hernandez, et al.Vaccine|August 25, 2024
Iridaea cordata lipid extract associated with the rCP01850 protein of C. pseudotuberculosis elicited a Th1 immune response in immunized sheepTallyson Nogueira Barbosa, Marcos Roberto Alves Ferreira, Nicole Ramos Scholl, et al.Vaccine|August 28, 2024
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccineShanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.Vaccine|August 30, 2024
How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?Adoración Navarro-Torné, Anja Anderson, Kavita Panwar, et al.Pageof 2,772